```html

Yellowed Conjunctiva (Scleral Icterus)

What is Yellowed Conjunctiva (Scleral Icterus)?

Yellowed conjunctiva, also called scleral icterus, is a clinical finding in which the normally white part of the eye (the sclera) and the inner lining of the eyelids (the conjunctiva) take on a yellow hue. The discoloration occurs when excess bilirubin— a yellow‑pigmented breakdown product of red blood cells—accumulates in the blood and deposits in tissues with a rich blood supply, such as the eye. Because the sclera is thin and highly vascular, it becomes one of the earliest and most noticeable places where jaundice can be observed.

While a yellow eye does not itself cause pain or vision loss, it is a visual clue that something is happening systemically, most often involving the liver, gallbladder, or red‑cell metabolism. Identifying scleral icterus helps clinicians prioritize further evaluation and, when coupled with other findings, can be life‑saving.

Common Causes

Below are the most frequent medical conditions that can lead to yellowed conjunctiva. Some are benign, while others require urgent treatment.

• Hepatocellular injury – acute hepatitis (viral, drug‑induced, alcoholic) or chronic cirrhosis reduces the liver’s ability to conjugate and excrete bilirubin.
• Obstructive (cholestatic) jaundice – gallstones, biliary strictures, pancreatic cancer, or primary sclerosing cholangitis block bile flow, causing bilirubin buildup.
• Hemolytic anemia – rapid destruction of red blood cells (e.g., sickle cell disease, G6PD deficiency, autoimmune hemolysis) overwhelms the liver’s capacity to process bilirubin.
• Genetic disorders – Gilbert’s syndrome and Crigler‑Najjar type II produce mild to moderate unconjugated hyperbilirubinemia.
• Drug‑induced liver injury – acetaminophen overdose, isoniazid, certain antibiotics, and many herbal supplements can cause acute liver failure.
• Sepsis or severe infection – systemic inflammation can impair hepatic perfusion and bilirubin clearance.
• Neonatal jaundice – immature liver enzymes in newborns often cause transient bilirubin rise; severe cases may lead to kernicterus.
• Pancreatitis – inflammation of the pancreas can compress the common bile duct, producing a cholestatic picture.
• Malignancy – hepatocellular carcinoma, metastatic disease to the liver, or lymphoma can impair bilirubin metabolism.
• Inherited metabolic disorders – Dubin‑Johnson and Rotor syndromes affect bilirubin transport, leading to conjugated hyperbilirubinemia.

Associated Symptoms

Patients with scleral icterus often report or are found to have other systemic signs that point toward the underlying cause.

• Fatigue and weakness – common in liver disease and hemolysis.
• Abdominal pain or fullness – especially in the right upper quadrant (gallbladder, liver) or epigastrium (pancreas).
• Dark urine and pale stools – indicate conjugated bilirubin spilling into the urine.
• Pruritus (itching) – bile salts deposited in the skin are typical of cholestasis.
• Swelling of the abdomen (ascites) or legs (edema) – sign of advanced liver disease.
• Nausea, vomiting, or loss of appetite – non‑specific but common in hepatobiliary disorders.
• Fever or chills – can suggest infection (e.g., cholangitis, sepsis).
• Jaundice of the skin – once bilirubin reaches ~2–3 mg/dL, the skin takes on a yellow tint, usually beginning on the face and progressing downwards.
• Bruising or easy bleeding – impaired synthesis of clotting factors in liver disease.
• Shortness of breath or chest pain – may accompany severe hemolysis or anemia.

When to See a Doctor

Yellowing of the eyes should never be ignored, especially if it appears suddenly or is accompanied by any of the following:

• Fever > 38 °C (100.4 °F) or chills.
• Severe abdominal pain, especially in the right upper quadrant.
• Confusion, lethargy, or a sudden change in mental status.
• Vomiting blood (hematemesis) or black, tar‑like stools (melena).
• Rapid heart rate (tachycardia) or low blood pressure (hypotension).
• Sudden worsening of jaundice with itching, swelling, or dark urine.
• History of recent medication change, overdose, or herbal supplement use.
• Known liver disease, hemoglobinopathy, or recent blood transfusion.

In these situations, seek care promptly—most often at an urgent care center or emergency department.

Diagnosis

Diagnosing the cause of scleral icterus involves a stepwise approach: clinical evaluation, laboratory tests, and imaging studies.

1. Clinical History & Physical Examination

• Onset and progression of yellowing.
• Medication, alcohol, and supplement use.
• Travel history, sexual exposure, and family history of liver disease.
• Examination of the abdomen for hepatomegaly, palpable gallbladder, or tenderness.
• Assessment for signs of chronic liver disease: spider angiomas, palmar erythema, caput medusae.

2. Laboratory Tests

Test	What It Shows
Serum bilirubin (total & direct)	Distinguishes unconjugated vs. conjugated hyperbilirubinemia.
ALT, AST, ALP, GGT	Patterns help differentiate hepatocellular injury (ALT/AST ↑) from cholestasis (ALP/GGT ↑).
Complete blood count	Hemolysis may show anemia, reticulocytosis, and low haptoglobin.
LDH & peripheral smear	Elevated in hemolytic anemias.
Coagulation profile (PT/INR)	Assess liver synthetic function.
Serologies	Hepatitis A/B/C, HIV, EBV, CMV as indicated.
Autoimmune markers	ANA, SMA, LKM‑1 for autoimmune hepatitis.

3. Imaging

• Abdominal ultrasound – first‑line to evaluate liver size, gallstones, bile duct dilation.
• CT or MRI – detailed view for masses, pancreatic tumors, or vascular abnormalities.
• MRCP (magnetic resonance cholangiopancreatography) – non‑invasive visualization of the biliary tree.

4. Specialized Tests (if needed)

• Endoscopic retrograde cholangiopancreatography (ERCP) – both diagnostic and therapeutic for bile‑duct blockages.
• Liver biopsy – to assess fibrosis, inflammation, or infiltrative disease when non‑invasive studies are inconclusive.
• Genetic testing – for suspected hereditary bilirubin disorders.

Treatment Options

Treatment is directed at the underlying cause; the yellow eye itself resolves once bilirubin levels drop.

1. Hepatocellular Injuries

• Acute viral hepatitis – supportive care (hydration, nutrition). Antiviral therapy for hepatitis B or C when indicated.
• Drug‑induced liver injury – immediate cessation of the offending agent; N‑acetylcysteine for acetaminophen toxicity.
• Alcoholic hepatitis – abstinence, nutritional support, corticosteroids in severe cases.

2. Obstructive (Cholestatic) Causes

• Endoscopic removal of gallstones (ERCP) or surgical cholecystectomy for gallstone disease.
• Stenting or surgical bypass for malignant biliary obstruction.
• Ursodeoxycholic acid to improve bile flow in certain cholestatic disorders.

3. Hemolytic Anemias

• Transfusion of packed red cells for severe anemia.
• Specific therapies (e.g., steroids for autoimmune hemolysis, ribavirin for chronic hepatitis C‑related mixed cryoglobulinemia, hydroxyurea for sickle cell disease).
• Folate supplementation to support erythropoiesis.

4. Supportive & Symptomatic Care

• Hydration and balanced diet rich in protein and vitamins.
• Pruritus relief: cholestyramine, antihistamines, or topical menthol creams.
• Photoprotection – protect skin from sunburn, as jaundiced skin can be more sensitive.

5. Home Measures While Awaiting Care

• Stay hydrated (aim for ≥ 2 L of water daily).
• Avoid alcohol and hepatotoxic medications (including over‑the‑counter NSAIDs unless cleared by a physician).
• Maintain a low‑fat, high‑protein diet if gallbladder disease is suspected.
• Monitor urine color (dark) and stool color (pale) and record changes for the clinician.

Prevention Tips

While not all causes are preventable, many risk factors for yellowed conjunctiva can be modified.

• Vaccinate against hepatitis A and B.
• Limit alcohol intake to ≤ 1 drink per day for women and ≤ 2 drinks per day for men.
• Avoid unnecessary medications; discuss any new drug or supplement with your doctor.
• Practice safe sex and use sterile needles to reduce viral hepatitis transmission.
• Maintain a healthy weight and regular exercise to lower the risk of non‑alcoholic fatty liver disease (NAFLD).
• Promptly treat gallstone disease or biliary colic before blockage occurs.
• If you have a known hemolytic disorder, adhere to regular follow‑up and keep vaccinations up‑to‑date.
• Use sunscreen and wear protective clothing—some medications (e.g., certain antibiotics) increase photosensitivity and can worsen liver injury.

Emergency Warning Signs

References

• Mayo Clinic. “Jaundice.” https://www.mayoclinic.org. Accessed June 2026.
• CDC. “Hepatitis A, B, and C.” Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis. Accessed June 2026.
• NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Liver Disease and Jaundice.” https://www.niddk.nih.gov. Accessed June 2026.
• World Health Organization. “Guidelines for the Management of Viral Hepatitis.” WHO, 2023. https://www.who.int.
• Cleveland Clinic. “Bilirubin and Jaundice.” https://my.clevelandclinic.org. Accessed June 2026.
• Journal of Hepatology. “Management of Acute Liver Failure.” 2021;75(5):1230‑1245. DOI:10.1016/j.jhep.2021.07.012.

```